Earnings Labs
Cingulate Inc. logo

Cingulate Inc. (CING)

NASDAQ·Healthcare·Biotechnology

$4.84

-8.08%

Mkt Cap $29.49M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (1 analysts)

$11.00

Range $11.00$11.00

Implied Upside

+127.5%

Consensus $11.00 vs current $4.84